Elsholtzia fruticosa
(EF) is present in tropical regions
throughout South Asian countries as well as the Himalayas. Although it has been
used as a traditional medicine to treat digestive, respiratory, and inflammatory
issues, its effect on preadipocyte differentiation is unknown. In this study, we
examined the effects of a methanol extract prepared from EF on the
differentiation of 3T3-L1 preadipocytes. Cell differentiation was assessed by
microscopic observation and oil-red O staining. The expression of adipogenic and
lipogenic genes, including
PPARγ
and
C/EBPα
, was measured by western blot analysis and
quantitative real-time polymerase chain reaction (qRT–PCR), to provide
insight into adipogenesis and lipogenesis mechanisms. The results indicated that
EF promotes the differentiation of 3T3-L1 preadipocytes, with elevated lipid
accumulation occurring in a concentration-dependent manner without apparent
cytotoxicity. EF enhances the expression of adipogenic and lipogenic genes,
including
PPARγ
,
FABP4
,
adiponectin
, and
FAS
, at the mRNA and
protein levels. The effect of EF was more pronounced during the early and middle
stages of 3T3-L1 cell differentiation. Treatment with EF decreased C/EBP
homologous protein (CHOP) mRNA and protein levels, while increasing
C/EBPα and PPARγ expression. Treatment with EF resulted in the
upregulation of
cyclin E
and
CDK2
gene
expression within 24 h, followed by a decrease at 48 h, demonstrating the
early-stage impact of EF. A concomitant increase in cyclin-D1 levels was
observed compared with untreated cells, indicating that EF modulates lipogenic
and adipogenic genes through intricate mechanisms involving CHOP and cell cycle
pathways. In summary, EF induces the differentiation of 3T3-L1 preadipocytes by
increasing the expression of adipogenic and lipogenic genes, possibly through
CHOP and cell cycle-dependent mechanisms.